CAR-T Therapy for DLBCL – OncLive
OncLive |
CAR–T Therapy for DLBCL
OncLive Krishna V. Komanduri, MD: I think the next thing that's really exciting in non-Hodgkin's lymphoma right now, and certainly is a topic of a lot of focus at this meeting, is autologous cellular immunotherapy and CAR–T cell therapies. And I think we have … |
